The "Fair-Market Value Compensation Rates for Cardiology KOLs - China" report has been added to ResearchAndMarkets.com's offering.

KOL Compensation China Cardiology presents fair-market value (FMV) compensation rates for Chinese-based KOLs in Cardiology, by percentiles, with averages, for six (6) activities, for four (4) levels of Thought Leader influences (rare, international, national and local).

Payments made to physicians and thought leaders have been under scrutiny for a few years and companies have been working to adjust their rates to level with industry standards. Adjustments to "market" rates should be done periodically and are best done through 3rd party research, providing a fair and balanced assessment of rates.

These defensible market-based rate data are built directly from industry compensation paid to Healthcare Practitioners (HCPs) and Thought Leaders (KOLs). All KOL FMV rates reports represent fair-market value established using our reliable methodology of collecting data from industry professionals involved in defining compensation levels for exchanges with KOLs worldwide.

Establishing fair-market value compensation rates will:

• reduce the external perception of inappropriate inducement and limit regulatory and compliance risks.
• provide an independent reference for negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs).
• refine and support the development of fee schedules that are aligned with market conditions.
• competitively position the organization and support good business practices.

The data included in each report are an aggregate of collected data and not individual rates. In no event, companies and individuals who provided the data are identified to protect their identity.

KOL Compensation China Cardiology

Engage with Thought Leaders early. Recent research shows that less than 25% of pharmaceutical organizations begin working and involving Key Opinion Leaders during or before the clinical phase. Most - 63% - wait during phases 2 and 3 to start exchanging with Thought Leaders. This most likely does not yield the desired results for companies who look to maximize the outcome of any promising product.

Key Topics Covered:

• Use of the publisher's Copyrighted Materials
• Research Methodology
• Definitions
• Therapeutic Area
• Thought Leader Levels
• Flat Rates
• Hourly Rates
• Flat Rates
• Advisory Board Lead
• Advisory Board Non-lead
• Consulting Scientific/Clinical Content
• Consulting Commercial Content
• Speaking Scientific/Clinical Content
• Speaking Commercial Content
• Hourly Rates
• Advisory Board Lead
• Advisory Board Non-lead
• Consulting Scientific/Clinical Content
• Consulting Commercial Content
• Speaking Scientific/Clinical Content
• Speaking Commercial Content

For more information about this report visit https://www.researchandmarkets.com/r/wgir5b

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240712763493/en/